Circulating tumor DNA and bone marrow minimal residual disease negativity confers superior outcome for multiple myeloma patients

• Sridurga Mithraprabhu,
• John Reynolds,
• Hang Quach,
• Noemi Horvath,
• Ian Kerridge,
• Tiffany Khong,
• Brian GM Durie,
• Andrew Spencer

Affiliations

Sridurga Mithraprabhu

Australian Centre for Blood Diseases, Alfred Health – Monash University, Melbourne, Australia; Department of Malignant Haematology and Stem Cell Transplantation, Alfred Hospital, Melbourne

John Reynolds

Australian Centre for Blood Diseases, Alfred Health – Monash University, Melbourne, Australia; Department of Malignant Haematology and Stem Cell Transplantation, Alfred Hospital, Melbourne

Hang Quach

St.Vincent’s Hospital, University of Melbourne

Noemi Horvath

Royal Adelaide Hospital, Adelaide

Ian Kerridge

Royal North Shore Hospital, Sydney

Tiffany Khong

Australian Centre for Blood Diseases, Alfred Health – Monash University, Melbourne, Australia; Department of Malignant Haematology and Stem Cell Transplantation, Alfred Hospital, Melbourne

Brian GM Durie

Cedars-Sinai Comprehensive Cancer Center, Los Angeles, California

Andrew Spencer

Australian Centre for Blood Diseases, Alfred Health – Monash University, Melbourne, Australia; Department of Malignant Haematology and Stem Cell Transplantation, Alfred Hospital, Melbourne